You are here » Home » Companies » Company Overview » Mesco Pharmaceuticals Ltd

Mesco Pharmaceuticals Ltd.

BSE: 500274 Sector: Health care
NSE: MESCOPHARM ISIN Code: INE839X01015
BSE 00:00 | 28 Oct 4.33 -0.22
(-4.84%)
OPEN

4.33

HIGH

4.33

LOW

4.33

NSE 05:30 | 01 Jan Mesco Pharmaceuticals Ltd
OPEN 4.33
PREVIOUS CLOSE 4.55
VOLUME 400
52-Week high 7.70
52-Week low 3.61
P/E
Mkt Cap.(Rs cr) 9
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 4.33
CLOSE 4.55
VOLUME 400
52-Week high 7.70
52-Week low 3.61
P/E
Mkt Cap.(Rs cr) 9
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Mesco Pharmaceuticals Ltd. (MESCOPHARM) - Company History

Mesco Pharmaceuticals started commercial operations in Jun.'91 by venturing into seed-marketing of bulk drugs and formulations with the objective of later establishing facilities for manufacture of bulk drugs and formulations. It set up a formulation plant to manufacture injectables syrups ointments and tablets/capsules. The company in technical partnership with Merz Germany introduced two drugs -- Hepa Merz and Viru Merz -- for hepatitis (liver disorder) and herpes respectively. It is now developing drugs for cardio-vascular diseases and Parkinson's disease. Apart from Merz Mesco has technical agreements with two Chinese companies -- Guilin Pharmaceutical Factory and China Science & Resources Technology Trading Corporation.The company has expanded its marketing network to the CIS Italy Germany and Africa. It is setting up a multi-purpose bulk drug plant with sterile technology to manufacture the latest bulk drugs in technical collaboration with Chementechno Austria.During 1996-97 the company earned foreign exchange worth Rs 1.25 cr.

.